SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001694187-19-000054
Filing Date
2019-06-27
Accepted
2019-06-27 08:28:19
Documents
2
Period of Report
2019-06-25

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_156163848249549.html 4  
1 FORM 4 wf-form4_156163848249549.xml 4 3997
2 EXHIBIT 24.1 - POWER OF ATTORNEY (ZAUSNER) ex-24.htm EX-24 4016
  Complete submission text file 0001694187-19-000054.txt   9425
Mailing Address 40 ERIE STREET SUITE 110 CAMBRIDGE MA 02139
Business Address 40 ERIE STREET SUITE 110 CAMBRIDGE MA 02139 617-337-4701
Neon Therapeutics, Inc. (Issuer) CIK: 0001694187 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O NEON THERAPEUTICS, INC. 40 ERIE STREET, SUITE 110 CAMBRIDGE MA 02139
Business Address
Zausner Meryl (Reporting) CIK: 0001742142 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38551 | Film No.: 19923009